We track the weekly and YTD results of the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances.

Our Psychedelic Drug Stocks Index tracks the six largest stocks, by market capitalization, that research the treatment of mental illnesses with psychedelic substances.

The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up?

The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to fall in December, ending -60% for 2022.

The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week.